The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer

TY - JOUR

T1 - The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer

AU - Younis, Tallal

AU - Rayson, D.

AU - Skedgel, C.

PY - 2011

Y1 - 2011

KW - Ac chemotherapy

KW - Adjuvant therapy

KW - Breast cancer

KW - Chemotherapy

KW - Cost-utility analysis

KW - Tc chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=82955169580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955169580&partnerID=8YFLogxK

U2 - 10.3747/co.v18i6.810

DO - 10.3747/co.v18i6.810

M3 - Article

AN - SCOPUS:82955169580

SN - 1198-0052

VL - 18

SP - e288-e296

JO - Current Oncology

JF - Current Oncology

IS - 6

ER -